Cart
sales@molnova.com
Cilostamide
CAS No. 68550-75-4
Cilostamide( OPC3689 )
Catalog No. M20984 CAS No. 68550-75-4
Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 59 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 258 | In Stock |
|
| 100MG | 387 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCilostamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
DescriptionCilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsOPC3689
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number68550-75-4
-
Formula Weight342.43
-
Molecular FormulaC20H26N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL (90.53 mM)
-
SMILESCN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1
-
Chemical NameN-Cyclohexyl-N-methyl-4-(12-dihydro-2-oxo-6-quinolyloxy)butyramide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cilostamide affects in a concentration and exposure time-dependent manner the viability and the kinetics of in vitro maturation of caprine and bovine oocytes.[J]. Research in veterinary science 2018.
molnova catalog
related products
-
Tetomilast
Tetomilast (OPC-6535) is a superoxide anion production inhibitor that inhibits PDE4 and proinflammatory functions.
-
BI 1015550
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
-
Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
